In colorectal cancer (CRC) microsatellite-stable (MSS) subtypes, RTK-RAS and TGF-Beta pathway mutations were prominent—a finding validated in the independent CHORD cohort. This evidence concerns the gene TGFB1 and colorectal carcinoma.